95
|
278
|
3cc6A |
Crystal structure of kinase domain of protein tyrosine kinase 2 beta (ptk2b) |
90
|
272
|
3bymA |
X-ray co-crystal structure aminobenzimidazole triazine 1 bound to lck |
104
|
376
|
3cd3A |
Crystal structure of phosphorylated human feline sarcoma viral oncogene homologue (v-fes) in complex with staurosporine and a consensus peptide |
91
|
276
|
3bz3A |
Crystal structure analysis of focal adhesion kinase with a methanesulfonamide diaminopyrimidine inhibitor |
84
|
271
|
3byoA |
X-ray co-crystal structure of 2-amino-6-phenylpyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6h)-one 25 bound to lck |
77
|
271
|
3byuA |
Co-crystal structure of lck and aminopyrimidine reverse amide 23 |
88
|
278
|
3bi6A |
Wee1 kinase complex with inhibitor pd352396 |
0
|
7
|
3brhC |
Protein tyrosine phosphatase ptpn-22 (lyp) bound to the mono-phosphorylated lck active site peptide |
82
|
272
|
3bysA |
Co-crystal structure of lck and aminopyrimidine amide 10b |
114
|
373
|
3bkbA |
Crystal structure of human feline sarcoma viral oncogene homologue (v-fes) |
83
|
277
|
3bizA |
Wee1 kinase complex with inhibitor pd331618 |
73
|
263
|
3b2wA |
Crystal structure of pyrimidine amide 11 bound to lck |
56
|
134
|
3b71A |
Cd4 endocytosis motif bound to the focal adhesion targeting (fat) domain of the focal adhesion kinase |
86
|
273
|
3ad6A |
Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
88
|
271
|
3acjA |
Crystal structure of imidazo pyrimidine derivative bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
84
|
271
|
3ac5A |
Crystal structure of triazolo pyrimidine derivative bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
88
|
271
|
3ad5A |
Crystal structure of triazolone derivative bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
86
|
271
|
3ackA |
Crystal structure of pyrrolo pyrazine derivative bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
85
|
271
|
3ac3A |
Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
82
|
271
|
3ac4A |
Crystal structure of triazolo pyrimidine derivative bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
90
|
271
|
3ac8A |
Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
87
|
271
|
3ac2A |
Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
89
|
271
|
3ad4A |
Crystal structure of methoxy benzofuran derivative bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
88
|
271
|
3ac1A |
Crystal structure of pyrazin derivative bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
81
|
265
|
2zvaA |
Lyn tyrosine kinase domain-dasatinib complex |
62
|
268
|
3a4oX |
Lyn kinase domain |
73
|
264
|
2zv7A |
Lyn tyrosine kinase domain, apo form |
82
|
271
|
2zybA |
Crystal structure of phenylimidazo pyrazin 2 bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
75
|
264
|
2zv8A |
Lyn tyrosine kinase domain-amp-pnp complex |
78
|
264
|
2zv9A |
Lyn tyrosine kinase domain-pp2 complex |
80
|
271
|
2zm4A |
Crystal structure of imidazo quinoxaline 1 bound to the kinase domain of human lck, activated form (auto-phosphorylated on tyr394) |
88
|
284
|
2z60A |
Crystal structure of the t315i mutant of abl kinase bound with ppy-a |
1
|
50
|
2ys2A |
Solution structure of the btk motif of human cytoplasmic tyrosine-protein kinase bmx |
74
|
281
|
2z2wA |
Human wee1 kinase complexed with inhibitor pf0335770 |
8
|
109
|
2yt6A |
Solution structure of the sh3_1 domain of yamaguchi sarcoma viral (v-yes) oncogene homolog 1 |
34
|
167
|
2z0pA |
Crystal structure of ph domain of bruton's tyrosine kinase |
88
|
271
|
2zm1A |
Crystal structure of imidazo pyrazin 1 bound to the kinase domain of human lck, (auto-phosphorylated on tyr394) |
7
|
85
|
2yuqA |
Solution structure of the sh3 domain of human tyrosine-protein kinase itk/tsk |
7
|
83
|
2yuuA |
Solution structure of the first phorbol esters/diacylglycerol binding domain of human protein kinase c, delta |
78
|
266
|
2xynA |
Human abl2 in complex with aurora kinase inhibitor vx-680 |
92
|
288
|
2xa4A |
Inhibitors of jak2 kinase domain |
86
|
290
|
2w1iA |
Structure determination of aurora kinase in complex with inhibitor |
9
|
64
|
2rnaA |
Itk sh3 average minimized |
17
|
99
|
2rsyA |
Solution structure of the sh2 domain of csk in complex with a phosphopeptide from cbp |
81
|
270
|
2v7aA |
Crystal structure of the t315i abl mutant in complex with the inhibitor pha-739358 |
9
|
64
|
2rn8A |
Nmr structure note: murine itk sh3 domain |
134
|
450
|
2srcA |
Crystal structure of human tyrosine-protein kinase c-src, in complex with amp-pnp |
73
|
277
|
2qq7A |
Crystal structure of drug resistant src kinase domain with irreversible inhibitor |
70
|
278
|
2qlqA |
Crystal structure of src kinase domain with covalent inhibitor rl3 |
83
|
274
|
2qohA |
Crystal structure of abl kinase bound with ppy-a |